Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes or hypertension
Everything below is either preclinical animal work, a theoretical concern drawn from the proposed mechanism, or self-reported community anecdote each labeled by source class so the evidence weight is never blurred
For best results, take it with a small amount of water on an empty stomach and wait at least 30 minutes before eating, drinking, or taking other medications
One best thing is that these symptoms arent all in your head, and they are not always permanent
Aetna typically requires prior authorization for weight loss medications, including documentation of BMI, related health conditions, and prior weight loss efforts to determine coverage eligibility for drugs like Zepbound, Wegovy, or Saxenda